피플바이오, 내수 정체 속 중국 行…알츠온플러스 '새 실험'

PeopleBio’s launch of AlzOn+ in the Hainan Medical Zone represents a strategic pivot to overcome domestic stagnation and severe liquidity constraints through a pre-approval service model. This service-led entry is a crucial litmus test for the scalability of blood-based diagnostic tools in the global market, specifically targeting recurring hospital-based revenue.